Patricia Loughran

Patricia Loughran

Auto-generated profile, based on publicly available information

Patricia Loughran

Department of Surgery University of Pittsburgh Pittsburgh Pennsylvania

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MDMitchell R. Dyer
Mitchell R. Dyer
QCQiwei Chen
Qiwei Chen
SHShannon Haldeman
Shannon Haldeman
HYHamza Yazdani
Hamza Yazdani
RHRosemary Hoffman
Rosemary Hoffman
MNMatthew D. Neal
Matthew D. Neal
Venous thromboembolic (VTE) disease, consisting of deep venous thrombosis (DVT) and pulmonary embolism (PE) is a leading cause of morbidity and mortality. Current prophylactic measures are insufficient to prevent all occurrence in part due to an incomplete understanding of the underlying pathophysiology. Mounting evidence describes interplay between activation of the innate immune system and thrombus development. Recent work has demonstrated that platelet release of HMGB1 leads to increased microvascular complications following injury. Additionally, platelet HMGB1 was found to enhance DVT and increase the formation of neutrophil extracellular traps (NETs), although the role of HMGB1 induced NET release in thrombosis remains unexplored. Utilizing a transgenic mouse lacking HMGB1 specifically from platelets and megakaryocytes we now demonstrate the specific role of platelet-derived HMGB1 in acute and subacute/chronic venous thrombosis. Platelets account for the majority of circulating HMGB1 and HMGB1 deposition within the developing clot. The pro-thrombotic effect of platelet-derived HMGB1 is mediated through enhanced neutrophil recruitment, NET formation and specifically release of extracellular DNA during NET formation. Taken together, these data suggest that platelet HMGB1 mediated NET release is a primary regulator of DVT formation in mice.

1 January 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
STSamer Tohme
Samer Tohme
HYHamza O Yazdani
Hamza O Yazdani
VSVikas Sud
Vikas Sud
PLPatricia Loughran
Patricia Loughran
HHHai Huang
Hai Huang
ATAllan Tsung
Allan Tsung
Hepatic ischemia reperfusion (I/R) is a clinically relevant model of acute sterile inflammation leading to a reverberating, self-sustaining inflammatory response with resultant necrosis. We hypothesized that computerized dynamic network analysis (DyNA) of 20 inflammatory mediators could help dissect the sequence of post-I/R mediator interactions that induce injury. Although the majority of measured inflammatory mediators become elevated in the first 24 h, we predicted that only a few would be secreted early in the process and serve as organizational centers of downstream intermediator complexity. In support of this hypothesis, DyNA inferred a central organizing role for IL-17A during the first 3 h of reperfusion. After that, DyNA revealed connections among almost all the inflammatory mediators, representing an ongoing cytokine storm. Blocking IL-17A immediately after reperfusion disassembled the inflammatory networks and protected the liver from injury. Disassembly of the networks was not achieved if IL-17A blockage was delayed two or more hours postreperfusion. Network disassembly was accompanied by decrease in neutrophil infiltration and neutrophil extracellular trap (NET) formation. By contrast, administration of recombinant IL-17A increased neutrophil infiltration, NET formation, and liver necrosis. The administration of DNase, a NET inhibitor, significantly reduced hepatic damage despite prior administration of IL-17A, and DNase also disassembled the inflammatory networks. In vitro, IL-17A was a potent promoter of NET formation. Therefore, computational analysis identified IL-17A’s early, central organizing role in the rapid evolution of a network of inflammatory mediators that induce neutrophil infiltration and NET formation responsible for hepatic damage after liver I/R.

25 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
JLJunke Long
Junke Long
CYChenxuan Yang
Chenxuan Yang
YZYawen Zheng
Yawen Zheng
PLPatricia Loughran
Patricia Loughran
FGFu Guang
Fu Guang
MDMeihong Deng
Meihong Deng
Notch or STING, which is in charge of CD4 T cell fate?

1 April 2011 in Journal of Surgical Research
Verified
Journal Article
Open access
CMChristoph L. Menzel
Christoph L. Menzel
Ass Prof. Dr. Roman PfeiferAss Prof. Dr. Roman Pfeifer
Ass Prof. Dr. Roman Pfeifer
SDSophie S. Darwiche
Sophie S. Darwiche
PKPhilipp Kobbe
Philipp Kobbe
RGRoop Gill
Roop Gill
HPHans-Christoph Pape
Hans-Christoph Pape
Post-traumatic inflammatory changes have been identified as major causes of altered organ function and failure. Both hemorrhage and soft tissue damage induce these inflammatory changes. Exposure to heterologous bone in animal models has recently been shown to mimic this inflammatory response in a stable and reproducible fashion. This follow-up study tests the hypothesis that inflammatory responses are comparable between a novel trauma model ("pseudofracture", PFx) and a bilateral femur fracture (BFF) model. In C57BL/6 mice, markers for remote organ dysfunction and inflammatory responses were compared in four groups (control/sham/BFF/PFx) at the time points 2, 4, and 6 h. Hepatocellular damage in BFF and PFx was highly comparable in extent and evolution, as shown by similar levels of NFkappaB activation and plasma ALT. Pulmonary inflammatory responses were also comparably elevated in both trauma models as early as 2 h after trauma as measured by myeloperoxidase activity (MPO). Muscle damage was provoked in both BFF and PFx mice over the time course, although BFF induced significantly higher AST and CK levels. IL-6 levels were also similar with early and sustained increases over time in both trauma models. Both BFF and PFx create similar reproducible inflammatory and remote organ responses. PFx will be a useful model to study longer term inflammatory effects that cannot be studied using BFF.

1 June 2001 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
RZRuben Zamora
Ruben Zamora
YVYoram Vodovotz
Yoram Vodovotz
LALouis Alarcon
Louis Alarcon
BBBinnie Betten
Binnie Betten
PLPatricia A. Loughran
Patricia A. Loughran
Timothy R. BilliarTimothy R. Billiar
Timothy R. Billiar

1 October 2016 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
DWDirk Van Der Windt
Dirk Van Der Windt
HYHamza O. Yazdani
Hamza O. Yazdani
HCHui-Wei Chen
Hui-Wei Chen
BRBrian R. Rosborough
Brian R. Rosborough
PLPatricia Loughran
Patricia Loughran
HHHai Huang
Hai Huang